9 results on '"Mangino, Massimo"'
Search Results
2. IRF4 variants have age-specific effects on nevus count and predispose to melanorha
- Author
-
Duffy, David L., Iles, Mark M., Glass, Dan, Zhu, Gu, Barrett, Jennifer H., Hoiom, Veronica, Zhao, Zhen Z., Sturm, Richard A., Soranzo, Nicole, Hammond, Chris, Kvaskoff, Marina, Whiteman, David C., Mangino, Massimo, Hansson, Johan, Newton-Bishop, Julia A., Bataille, Veronique, Hayward, Nicholas K., Martin, Nicholas G., Bishop, D. Timothy, Spector, Timothy D., and Montgomery, Grant W.
- Subjects
Melanoma -- Genetic aspects ,Melanoma -- Demographic aspects ,Population genetics -- Research ,Sun exposure -- Health aspects ,Teenagers -- Genetic aspects ,Teenagers -- Physiological aspects ,Youth -- Genetic aspects ,Youth -- Physiological aspects ,Biological sciences - Published
- 2010
3. Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control
- Author
-
Ferreira, Manuel A.R., Mangino, Massimo, Brumme, Chanson J., Zhen Zhen Zhao, Medland, Sarah E., Nyholt, Dale R., Wright, Margaret J., Gordon, Scott, Campbell, Megan, Henders, Anjali, Evans, David M., Lanchbury, Jerry S., Pereyra, Florencia, McEvoy, Brian P., Walker, Bruce D., Haas, David W., Soranzo, Nicole, Spector, Tim D., de Bakker, Paul I.W., Frazer, Ian H., Montgomery, Grant W., and Martin, Nicholas G.
- Subjects
HIV infection -- Genetic aspects ,HIV infection -- Risk factors ,Immunologic diseases -- Genetic aspects ,Lymphocytes -- Health aspects ,Major histocompatibility complex -- Research ,Quantitative trait loci -- Research ,Type 1 diabetes -- Genetic aspects ,Type 1 diabetes -- Risk factors ,Biological sciences - Abstract
A study identifies genetic predictors of lymphocyte levels, which are hypothesized to be associated with immune-related diseases, and tests several variants of CD4+ T cells, CD8+ T cells, CD56+ natural killer (NK) cells and the derived CD4:CD8 ratio associated with five lymphocyte subsets. It identifies two major independent quantitative trait loci (QTL) for CD4:CD8 lymphocyte ratio, wherein CD4 and CD8 are associated with risk of type-1 diabetes and HIV-1 immune control, respectively.
- Published
- 2010
4. MP-470543-005 UNSUPERVISED ECG FEATURE EXTRACTION USING DEEP LEARNING EMPOWERS DISCOVERY OF GENETIC DETERMINANTS OF CARDIAC ELECTROPHYSIOLOGY.
- Author
-
Sieliwonczyk, Ewa, Sau, Arunashis, Patlatzoglou, Konstantinos, McGurk, Kathryn, Pastika, Libor, Thami, Prisca, Mangino, Massimo, Zheng, Sean, Powell, George, Curran, Lara, Buchan, Rachel, Theotokis, Pantazis, Peters, Nicholas S., Loeys, Bart, Kramer, Daniel B., Waks, Jonathan, Ng, Fu Siong, and Ware, James S.
- Published
- 2024
- Full Text
- View/download PDF
5. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies.
- Author
-
Gielen, Marij, Hageman, Geja J, Antoniou, Evangelia E, Nordfjall, Katarina, Mangino, Massimo, Balasubramanyam, Muthuswamy, Meyer, Tim de, Hendricks, Audrey E, Giltay, Erik J, Hunt, Steven C, Nettleton, Jennifer A, Salpea, Klelia D, Diaz, Vanessa A, Farzaneh-Far, Ramin, Atzmon, Gil, Harris, Sarah E, Hou, Lifang, Gilley, David, Hovatta, Iiris, and Kark, Jeremy D
- Subjects
TELOMERES ,AGE distribution ,BODY weight ,CONFIDENCE intervals ,ETHNIC groups ,INTERPROFESSIONAL relations ,LIFE expectancy ,META-analysis ,SCIENTIFIC observation ,REGRESSION analysis ,SEX distribution ,SYSTEMATIC reviews ,BODY mass index ,CROSS-sectional method ,PHYSIOLOGY - Abstract
Background: Even before the onset of age-related diseases, obesity might be a contributing factor to the cumulative burden of oxidative stress and chronic inflammation throughout the life course. Obesity may therefore contribute to accelerated shortening of telomeres. Consequently, obese persons are more likely to have shorter telomeres, but the association between body mass index (BMI) and leukocyte telomere length (TL) might differ across the life span and between ethnicities and sexes. Objective: A collaborative cross-sectionalmeta-analysis of observational studies was conducted to investigate the associations between BMI and TL across the life span. Design: Eighty-seven distinct study samples were included in the meta-analysis capturing data from 146,114 individuals. Studyspecific age- and sex-adjusted regression coefficients were combined by using a random-effects model in which absolute [base pairs (bp)] and relative telomere to single-copy gene ratio (T/S ratio) TLs were regressed against BMI. Stratified analysis was performed by 3 age categories (“young”: 18–60 y; “middle”: 61–75 y; and “old”: >75 y), sex, and ethnicity. Results: Each unit increase in BMI corresponded to a−3.99 bp (95% CI: −5.17, −2.81 bp) difference in TL in the total pooled sample; among young adults, each unit increase in BMI corresponded to a −7.67 bp (95% CI:−10.03,−5.31 bp) difference. Each unit increase in BMI corresponded to a −1.58 × 10
−3 unit T/S ratio (0.16% decrease; 95% CI: −2.14 × 10−3 , −1.01 × 10−3 ) difference in ageand sex-adjusted relative TL in the total pooled sample; among young adults, each unit increase in BMI corresponded to a −2.58 × 10−3 unit T/S ratio (0.26% decrease; 95% CI: −3.92 × 10−3 , −1.25 × 10−3 ). The associations were predominantly for the white pooled population. No sex differences were observed. Conclusions: A higher BMI is associated with shorter telomeres, especially in younger individuals. The presently observed difference is not negligible. Meta-analyses of longitudinal studies evaluating change in body weight alongside change in TL are warranted. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
6. LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians
- Author
-
Mangino, Massimo, Braund, Peter, Singh, Ravi, Steeds, Rick, Thompson, John R., Channer, Kevin, and Samani, Nilesh J.
- Subjects
- *
MYOCARDIAL infarction , *CORONARY disease , *HEART diseases , *NECROSIS - Abstract
Abstract: Myocardial infarction (MI) is currently among the leading causes of death in the developed world. A functional SNP (rs7291467) in galectin-2 (LGALS2), a protein involved in the LTA cascade, has been associated with susceptibility to MI in the Japanese population. We explored for the first time the hypothesis that the same SNP could be associated with the risk of MI in the British population. We conducted a case–control association study on a cohort of 752 British MI patients and 705 population controls. Power calculations showed that our resource had 98% of power to detect a significant association at OR of 1.57, and 80% power to detect an association with an OR of 1.35 (recessive model). Despite this, we found no significant association of allele frequency with risk of MI. Stratification for age, gender and other cardiovascular risk factors also failed to reveal an association of this polymorphism with MI. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
7. Arachidonate 5-lipoxygenase (5-LO) promoter genotype and risk of myocardial infarction: A case–control study
- Author
-
Maznyczka, Annette, Braund, Peter, Mangino, Massimo, and Samani, Nilesh J.
- Subjects
- *
LEUKOTRIENES , *LIPOXYGENASES , *MYOCARDIAL infarction , *ATHEROSCLEROSIS - Abstract
Abstract: Background: Leukotrienes are inflammatory mediators derived from arachidonic acid via the 5-lipoxygenase pathway. Both experimental and clinical studies implicate the 5-lipoxygenase pathway in the pathophysiology of atherosclerosis. In a previous study, a microsatellite polymorphism in the 5-lipoxygenase gene promoter involving the binding site for the transcription factor Sp1, was associated with carotid intima media thickness (CIMT). Compared to subjects carrying the common allele, subjects carrying two variant alleles had significantly greater CIMT. Elevated CIMT is a risk factor for coronary events. In this study we investigated whether carriage of two variants alleles for the 5-lipoxygenase promoter polymorphism is associated with increased risk of myocardial infarction (MI). Methods: 1464 subjects, comprising 746 MI cases (under 65 years of age) and 718 controls, were genotyped for the 5-lipoxygenase microsatellite polymorphism by PCR amplification of the promoter region and allele discrimination by capillary electrophoresis. Results: The distribution of subjects grouped into those homozygote for the common allele, subjects carrying one variant allele, and subjects carrying two variant alleles was similar in cases and controls (cases: 66.9%/29.8%/3.3%, controls: 66.0%/29.4%/4.6%, p =0.48). The odds ratio for MI for subjects carrying two variant alleles compared to subjects carrying at least one common allele was 0.72 (95% CI: 0.42–1.22, p =0.22). The odds ratio was not affected by adjustment for other demographic risk factors. Conclusions: Despite their association with a marker of atherosclerosis, variant 5-lipoxygenase promoter genotypes are not a major risk factor for MI, at least in Caucasian subjects of Northern European origin. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
8. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.
- Author
-
Menni, Cristina, Klaser, Kerstin, May, Anna, Polidori, Lorenzo, Capdevila, Joan, Louca, Panayiotis, Sudre, Carole H, Nguyen, Long H, Drew, David A, Merino, Jordi, Hu, Christina, Selvachandran, Somesh, Antonelli, Michela, Murray, Benjamin, Canas, Liane S, Molteni, Erika, Graham, Mark S, Modat, Marc, Joshi, Amit D, and Mangino, Massimo
- Subjects
- *
COVID-19 , *SARS-CoV-2 , *VACCINATION , *VACCINE effectiveness , *COVID-19 vaccines , *INFECTION , *RESEARCH funding - Abstract
Background: The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We aimed to investigate the safety and effectiveness of these vaccines in a UK community setting.Methods: In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine. We also compared infection rates in a subset of vaccinated individuals subsequently tested for SARS-CoV-2 with PCR or lateral flow tests with infection rates in unvaccinated controls. All analyses were adjusted by age (≤55 years vs >55 years), sex, health-care worker status (binary variable), obesity (BMI <30 kg/m2vs ≥30 kg/m2), and comorbidities (binary variable, with or without comorbidities).Findings: Between Dec 8, and March 10, 2021, 627 383 individuals reported being vaccinated with 655 590 doses: 282 103 received one dose of BNT162b2, of whom 28 207 received a second dose, and 345 280 received one dose of ChAdOx1 nCoV-19. Systemic side-effects were reported by 13·5% (38 155 of 282 103) of individuals after the first dose of BNT162b2, by 22·0% (6216 of 28 207) after the second dose of BNT162b2, and by 33·7% (116 473 of 345 280) after the first dose of ChAdOx1 nCoV-19. Local side-effects were reported by 71·9% (150 023 of 208 767) of individuals after the first dose of BNT162b2, by 68·5% (9025 of 13 179) after the second dose of BNT162b2, and by 58·7% (104 282 of 177 655) after the first dose of ChAdOx1 nCoV-19. Systemic side-effects were more common (1·6 times after the first dose of ChAdOx1 nCoV-19 and 2·9 times after the first dose of BNT162b2) among individuals with previous SARS-CoV-2 infection than among those without known past infection. Local effects were similarly higher in individuals previously infected than in those without known past infection (1·4 times after the first dose of ChAdOx1 nCoV-19 and 1·2 times after the first dose of BNT162b2). 3106 of 103 622 vaccinated individuals and 50 340 of 464 356 unvaccinated controls tested positive for SARS-CoV-2 infection. Significant reductions in infection risk were seen starting at 12 days after the first dose, reaching 60% (95% CI 49-68) for ChAdOx1 nCoV-19 and 69% (66-72) for BNT162b2 at 21-44 days and 72% (63-79) for BNT162b2 after 45-59 days.Interpretation: Systemic and local side-effects after BNT162b2 and ChAdOx1 nCoV-19 vaccination occur at frequencies lower than reported in phase 3 trials. Both vaccines decrease the risk of SARS-CoV-2 infection after 12 days.Funding: ZOE Global, National Institute for Health Research, Chronic Disease Research Foundation, National Institutes of Health, UK Medical Research Council, Wellcome Trust, UK Research and Innovation, American Gastroenterological Association. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
9. Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals.
- Author
-
Noordam, Raymond, Young, William J, Salman, Reem, Kanters, Jørgen K, van den Berg, Marten E, van Heemst, Diana, Lin, Henry J, Barreto, Sandhi Maria, Biggs, Mary L, Biino, Ginevra, Catamo, Eulalia, Concas, Maria Pina, Ding, Jun, Evans, Daniel S, Foco, Luisa, Grarup, Niels, Lyytikäinen, Leo-Pekka, Mangino, Massimo, Mei, Hao, and van der Most, Peter J
- Subjects
- *
CARDIOVASCULAR disease diagnosis , *RESEARCH , *RESEARCH methodology , *CARDIOVASCULAR diseases , *POTASSIUM , *EVALUATION research , *MEDICAL cooperation , *COMPARATIVE studies , *ELECTROCARDIOGRAPHY , *MAGNESIUM , *HEART function tests , *SYMPTOMS , *RESEARCH funding , *CALCIUM , *HEART conduction system - Abstract
Background: Subclinical changes on the electrocardiogram are risk factors for cardiovascular mortality. Recognition and knowledge of electrolyte associations in cardiac electrophysiology are based on only in vitro models and observations in patients with severe medical conditions.Objectives: This study sought to investigate associations between serum electrolyte concentrations and changes in cardiac electrophysiology in the general population.Methods: Summary results collected from 153,014 individuals (54.4% women; mean age 55.1 ± 12.1 years) from 33 studies (of 5 ancestries) were meta-analyzed. Linear regression analyses examining associations between electrolyte concentrations (mmol/l of calcium, potassium, sodium, and magnesium), and electrocardiographic intervals (RR, QT, QRS, JT, and PR intervals) were performed. The study adjusted for potential confounders and also stratified by ancestry, sex, and use of antihypertensive drugs.Results: Lower calcium was associated with longer QT intervals (-11.5 ms; 99.75% confidence interval [CI]: -13.7 to -9.3) and JT duration, with sex-specific effects. In contrast, higher magnesium was associated with longer QT intervals (7.2 ms; 99.75% CI: 1.3 to 13.1) and JT. Lower potassium was associated with longer QT intervals (-2.8 ms; 99.75% CI: -3.5 to -2.0), JT, QRS, and PR durations, but all potassium associations were driven by use of antihypertensive drugs. No physiologically relevant associations were observed for sodium or RR intervals.Conclusions: The study identified physiologically relevant associations between electrolytes and electrocardiographic intervals in a large-scale analysis combining cohorts from different settings. The results provide insights for further cardiac electrophysiology research and could potentially influence clinical practice, especially the association between calcium and QT duration, by which calcium levels at the bottom 2% of the population distribution led to clinically relevant QT prolongation by >5 ms. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.